Ligand Pharmaceuticals completes acquisition of XOMA Royalty for $39 per share
Ligand Pharmaceuticals Incorporated completed its acquisition of XOMA Royalty Corporation on July 14, 2026.
$39.00cash75%proceeds
Company
SEC filing news and material events for XOMA Royalty Corp, briefed from primary-source filings.
1 story
Ligand Pharmaceuticals Incorporated completed its acquisition of XOMA Royalty Corporation on July 14, 2026.